Lev Facher

Washington Correspondent

Lev Facher is a Washington Correspondent for STAT, reporting on the politics of health, medicine, and life sciences. He's a recent graduate of the University of Michigan, where he studied economics and worked as the managing editor of The Michigan Daily.

Vitamin pills

Pharma

Number of drug makers lobbying Congress on pricing issues skyrockets

Facebook Opioid Policy

Health

Facebook to redirect users searching for opioids to federal crisis help line

Drug Control Chaos

Politics

Empty desks, squabbles, inexperienced staff: Exactly who is coordinating White House drug policy?

Paul Ryan, Kevin McCarthy, Greg Walden

Politics

Major opioids legislation is taking shape. Can it make a dent in a national epidemic?

Politics

NIH spells out $500 million plan to improve addiction treatment and pain management

Truth Opioid Epidemic

Health

Crashing cars into walls, breaking hands with hammers: How the White House is warning against opioids

Opioid Lobbying

Politics

As opioids legislation gains steam, efforts to address crisis collide with moneyed interests

Opioid Prescriptions

Politics

FDA targets websites illegally marketing opioids — and presses tech giants to step up

By Lev Facher and Ike Swetlitz

Gabapentinoids Abuse

Politics

FDA officials warn about the ‘next wave’ of drug abuse: opioid substitutes

FDA Opioid Tech

Politics

Facebook, Instagram among tech firms called to Washington by FDA to address illicit opioid sales

Politics

Senator, blocking subpoena of Teva in opioids probe, says matter should be left to courts

Norman Sharpless

Health

The head of the National Cancer Institute on hopes for AI, the future of precision medicine, and big data

Opioid Withdrawal

Health

In a first, FDA approves drug meant to mitigate symptoms of opioid withdrawal

Drug Prices Lobbying

Politics

As Trump railed against the ‘drug lobby,’ lawmakers funded by pharma watched from Rose Garden

Alex Azar

Politics

Azar, striking an aggressive tone, suggests Trump will call out drug companies behind major price hikes

Alex Azar

Politics

From drug ads to Medicare moves, 5 policy takeaways from Trump’s drug pricing speech

By Ike Swetlitz, Erin Mershon, and Lev Facher

Patrick Morrisey

Politics

A contentious West Virginia Senate race pits two candidates with close ties to pharma

Opioid Hearing

Politics

Congressman to drug distributors: ‘I just want you to feel shame’

« Previous Page